Catalyst

Slingshot members are tracking this event:

ANI Pharmaceuticals and Dexcel Announce FDA Approval of Donepezil Hydrochloride 23mg Tablets

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
ANIP Community voting in process

Additional Information

Additional Relevant Details ANI Pharmaceuticals announced that its collaboration partner Dexcel Pharma Technologies Ltd. (Dexcel) has received approval from the U.S. Food and Drug Administration (FDA) of the Abbreviated New Drug Application (ANDA) for Donepezil HCl 23mg Tablets. Sales of the product for calendar year 2015 were $44 million, according to IMS Health, with five current generic competitors. ANI and Dexcel expect to begin shipping to customers shortly.
http://www.anipharma...
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 24, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Dexcel, Alzheimer, Efficacy, Mild, Moderate